Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 2/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20253620 | 0.83 | TSHR (0.68) | CYP2D6TSHRALDH1A1MAPT | |
| SCHEMBL18175915 | 0.80 | EPHX1 (0.44) | POLBTSHRALDH1A1MAPTEPHX1 | |
| SCHEMBL10001744 | 0.79 | TSHR (0.67) | CYP2D6POLBTSHRALDH1A1MAPT | |
| SCHEMBL1692429 | 0.79 | TSHR (0.67) | CYP2D6POLBTSHRALDH1A1MAPT | |
| SCHEMBL8168248 | 0.79 | TSHR (0.67) | CYP2D6POLBTSHRALDH1A1MAPT | |
| SCHEMBL487564 | 0.79 | TSHR (0.67) | CYP2D6POLBTSHRALDH1A1MAPT | |
| SCHEMBL487563 | 0.79 | TSHR (0.67) | CYP2D6POLBTSHRALDH1A1MAPT | |
| SCHEMBL6233713 | 0.79 | TSHR (0.67) | CYP2D6POLBTSHRALDH1A1MAPT | |
| SCHEMBL10001742 | 0.79 | TSHR (0.67) | CYP2D6POLBTSHRALDH1A1MAPT | |
| SCHEMBL9543017 | 0.79 | TSHR (0.67) | CYP2D6POLBTSHRALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11695158-B2 | Nonaqueous electrolyte, capacitor device using same, and carboxylic acid ester compound used in same | MU IONIC SOLUTIONS CORPORATION (JP) | 2023-07-04 | — | — | US | disclosed |
| US-11695158-B2 | Nonaqueous electrolyte, capacitor device using same, and carboxylic acid ester compound used in same | MU IONIC SOLUTIONS CORPORATION (JP) | 2023-07-04 | — | — | US | disclosed |
| US-20210320334-A1 | NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME | MU IONIC SOLUTIONS CORPORATION (JP) | 2021-10-14 | — | — | US | disclosed |
| US-20190198928-A1 | NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME | UBE INDUSTRIES, LTD. (JP) | 2019-06-27 | — | — | US | disclosed |
| US-10263285-B2 | Nonaqueous electrolyte, capacitor device using same, and carboxylic acid ester compound used in same | UBE INDUSTRIES, LTD. (JP) | 2019-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190198928-A1 | NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME | SLC9A2, VDAC1, SCO2 | CYP2D6 2869/4885POLB 4477/4885TSHR 2418/4885 |
| US-11695158-B2 | Nonaqueous electrolyte, capacitor device using same, and carboxylic acid ester compound used in same | SLC9A2, VDAC1, SCO2 | CYP2D6 2869/4885POLB 4477/4885TSHR 2418/4885 |
| US-10263285-B2 | Nonaqueous electrolyte, capacitor device using same, and carboxylic acid ester compound used in same | SLC9A2, VDAC1, SCO2 | CYP2D6 2869/4885POLB 4477/4885TSHR 2418/4885 |
| US-20210320334-A1 | NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME | SLC9A2, VDAC1, SCO2 | CYP2D6 2869/4885POLB 4477/4885TSHR 2418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.